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The discovery that the oncogenes of acutely 
transforming retroviruses have their counter-
parts in normal cells and have actually arisen 
from these cellular genes has not only greatly 
influenced current views on the mechanisms 
of cell transformation, but has also had great 
impact on our thinking about the regulation of 
growth and differentiation. O ncogenes have 
turned out to code for molecules with a wide 
spectrum of different functions. As listed in 
Table 1 viral (reviewed in 1) and cellular on-
co genes have been found to be analogous of a) 
Table 1 Viral and cellular oncogenes 
v/c Size of 
oncogene protein product 
v/c-sis p28 
c-int-1 370aa 
c-int-2 
c-neu p'85 
v/c-erb B p72 
v/c-abl p150 p'45 
v/c-src ppso 
v/c-fes/fps p85 gag.fes 
v/c-yes pQOgag.yes 
v/c-fgr p70 gag.fgr 
v/c-fms p'20 
v/c-ros p62gag.ros 
v/c-rasHa p21 
v/c-rasKi p21 
c-rasN p21 
v/c-mil/raf1 p 100gag·mil 
raf2 
v/c-mos p40 
v/c-rel 
v/c-erbA p46 
p53 p53 
v/c-myc p60- 54 
N-myc 
L-myc 
v/c-fos pp55 
v/c-myb p75 
v/c-ski 
v/c-ets p54 
Proposed location 
of product 
secreted ; cytoplasm? 
plasma membrane 
plasma membrane, ER, 
Golgi apparatus 
plasma membrane 
plasma membrane 
plasma membrane 
plasma membrane, ER, 
Golgi apparatus 
plasma membrane 
plasma membrane 
plasma membrane 
cytoplasm 
cytoplasm 
cytoplasm 
cytoplasm/nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus, cytoplasm 
(fused with p-v-myb) 
Proposed function 
growth factor 
growth factor? 
protein tyrosine kinase 
protein tyrosine kinase 
protein tyrosine kinase 
protein tyrosine kinase 
protein tyrosine kinase 
protein tyrosine kinase 
protein tyrosine kinase 
protein tyrosine kinase 
protein tyrosine kinase 
GTPaseand 
regulates adenylate cyclase 
GTPase 
GTPase 
serine/threonine kinase 
(pseudogene) 
serine/threonine kinase 
regulates transcription 
binds DNA, regulates 
transcription? 
binds DNA, regulates 
transcription 
regulates transcription 
Homology to cellular 
genes/proteins 
PDGF-2/B 
EGF-R 
EGF-R 
CSF-1-R 
rho-gene family 
rho-gene family 
rho-gene family 
proEGF 
src-gene family 
thyroid/glucocorti-
coidR 
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growth factors (e. g. sis 2), b) growth factor re-
ceptors (erb B\ fms4), c) molecules involved 
in signal transduction from receptors into the 
interior of the cell (probably rass) and d) pro-
teins with nuclear localization. The last group 
seems to include proteins (e. g. erb A6) bind-
ing to regulatory elements within the DNA 
which could thus be responsible for turning 
on or off one or a number of genes whose pro-
ducts then, in turn, could be responsible for 
regulation of growth and differentiation. 
One of the most easily accessible systems to 
study these parameters in vitro are cells of the 
immune system. Over the last twenty years 
we have learned to manipulate T - and B-lym-
phocytes in vitro. It was therefore attractive to 
use in vitro lymphocytes growth and differen-
tiation for the analysis of cellular oncogene ex-
pression. 1983 Kelly et al. showed that murine 
spleen cells stimulated with T cell and B cell 
specific mitogens, i. e. Concanavalin A 
(ConA) and Lipopolysaccharide (LPS), re-
spectively, transiently expressed c-myc7. This 
finding has since been confirmed and extended 
by various groups, including our owns. We 
were particularly interested in the expression 
of c-myc and c-fos, another nuclear protein 
(see Table 1 and ref. 1). Lymphocytes were 
either stimulated in a way which would lead to 
their transition through a full cell cycle or 
under conditions which would only make 
them growth competent, e. i., transition 
through the cell cycle would depend on an ad-
ditional signal. 
1. Expression of e-mye in Mouse T Cells 
1.1 Nylon wool (NW) purified mouse T cells 
NW enriched mouse T cells were stimulated 
with either ConA (2.5 [tg/ml) or by 
leukoagglutinin (LA, 0.5 [tg/ml). As previ-
ously describeds and shown in Fig. 1, ConA 
leads to significant 3H-thymidine incorpora-
tion in such cells while LA does so only in the 
presence of rIL-2. ConA stimulation resulted 
in a maximal expression of c-myc mRNA as 
early as 3 h after activation, at 20 hand 48 h 
post stimulation c-myc mRNA levels were 
significantly decreased. In contrast, in T cells 
stimulated with LA in the absence of IL-2 and 
thus in the absence of actual growth, c-myc 
gene expression continuously increased from 
3 h until 48 h post stimulation. Addition of IL-
2 did not lead to a change in kinetics, but the 
signals of c-myc RNA observed at later times 
were stronger. 
1.2 Lyt2+ (CD8+) T cells 
Isolated Lyt2+ T cells activated by ConA or 
LA showed increased DNA synthesis only in 
the presence of IL-2 (ref. 8 and Fig. 2). When 
IL-2 was added, however, 3H-thymidine in-
corporation was identical in both cases. The 
kinetics of c-myc expression in ConA acti-
vated Lyt2+ cells was different from those ob-
served with unseparated T cells, the maxima 
being now shifted to 20 h post stimulation 
with or without Il-2,similar to the kinetics ob-
served upon LA stimulation of unseparated T 
cells. While ConA still led to some demon-
strable c-myc expression at 3 h post stimula-
tion, LA failed to do so although the prolifera-
tive capacity of both cultures upon IL-2 addi-
tion was identical. 
1.3 L3T4+ (CD4+) T cells 
A KLH specific and H_2d restricted L3T4+ T 
helper cell line was maintained by regular re-
stimulation. 6 h after restimulation by antigen 
and appropriate accessory cells, the cells ex-
pressed c-myc mRNA at maximal levels (Fig. 
3). Thereafter, c-myc specific mRNA de-
creased markedly. Helper type T cells thus 
displayed kinetics of c-myc gene expression 
similar to ConA stimulated unseparated 
splenic T cells. 
Taken together, these results suggested that 
kinetics of c-myc expression in mouse T cells 
are strongly influenced by the mitogen used 
and/or by the subpopulations investigated. 
They also indicated that expression of c-myc 
112 
a 
ConA 
myc 
2.4 kb ~ 
c 
150 
100 
50 
o 
j. Schneider-Schaulies, R. Knauer, A. Schimpl, E. Wecker 
o 3 20 48 h 
3H-Thymidine Incorporation 
,," 
,," 
,," 
,," 
.-""" ConA 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
: LA. 11-2 
I 
I 
I 
I 
I , 
I , 
I 
I 
I 
I 
I 
I 
I 
I 
: LA 
I 
I 
I 
24 72 h 
b 
LA 
11-2 
myc 
2.4 kb ~ 
o 3 3 20 20 4848 h 
+ + + 
only reflects competence for growth, but per 
se does not signify entrance into S-phase. 
2. Expression of c-myc in Mouse B Cells 
LPS activated B cells are able to proliferate and 
to mature to Ig secretion while cells activated 
with high doses of anti f.l F(ab'h only prolifer-
ate. Low doses of anti f.l F(ab')2 or intact anti f.l 
antibodies activate B cells neither to prolifera-
Fig. 1: C-myc mRNA expression in unseparated splenic T 
cells. 
a) Nylon wool purified splenic T cells were stimulated 
with ConA (2,5 [tg/ml) for 3,20 and 48 h. Total cellular 
RNA was blotted and hybridized to a c-myc specific 
probe. 
b) Nylon wool purified splenic T cells were stimulated 
with LA (0,5 [tg/ml) without and with rIL-2 (30 U/ 
ml). Total cellular RNA was blotted and hybridized to 
a c-myc specific probe. 
c) 3H-thymidine incorporation of ConA (_ - - - .); 
LA + IL-2 (.~.); LA (0 - - - 0) and serum alone 
(D - - - D) stimulated nylon wool purified splenic T 
cells. 
For all detailed experimental procedures see ref. 8. 
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Fig. 2: c-myc mRNA expression in Lyt2+ splenic T cells. 
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a) Lyt2 + cells were stimulated with ConA (2,5 flg /ml), ConA + IL-2 (30 D/ ml) or LA (0,5 flg/ml) + IL-2 for 3,20 and 
48 h. Total cellular RNA was blotted and hybridized to c-myc and c-Ha-ras specific probes. 
b) 3H-thymidine incorporation of Lyt2 + cells stimulated by ConA + IL-2 ( . - - - . ); LA + IL-2 (e - e ); 
ConA( D - -- D ) and LA (0 - - - 0). 
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Fig. 3: C-myc mRNA expression in L3T4+ cells (helper cell line). 
a) Northern blot of total cellular RNA hybridized to a c-myc specific probe. Lane 1 contains RNA from 12 h ConA + 
1 h CHI treated splenic cells. Lane 2 contains RNA from 1 h CHI treated quiescent L3T4+ cells. Lanes 3 to 8 contain 
RNA from L3T4+ cells stimulated for 0 (10 days), 3, 5,12,24 and 72 h by KLH (10 flg/ ml) + H_2b accessory cells, 
respectively. Lane 9 contains RNA from accessory cells alone. 
b) 3H-thymidine incorporation of L3T4+ cells stimulated by KLH + H_2b accessory cells (e - e ) and L3T4+ cells in 
medium without antigen and accessory cells (0 - - - 0 ). 
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tion nor maturation, but they do convey some 
early activation signal to the cells9,lO. These 
systems therefore allow to investigate c-myc 
expression under the various conditions of ac-
tivation (Fig. 4 a: LPS, 4 b: anti fA. F(ab')2' 4 c: 
anti fA. intact). The data show that c-myc ex-
pression in B cells stimulated with LPS or 
mitogenic doses of anti fA. F(ab')2 also reaches a 
maximum at about 6 hrs post stimulation just 
as shown above for T cells. Non mitogenic 
doses of anti fA. F(ab')2 which only induce 
growth competence, but no S phase transition 
also lead to elevated c-myc mRNA levels and 
the kinetics of expression are similar to those 
observed in optimally activated cells (data not 
shown). On the other hand, intact anti fA. an-
tibodies only induce low levels of c-myc 
mRNA 1 hr post activation which rapidly dis-
appears (Fig. 4 c). Thus c-myc expression 
again best correlates with priming signals or 
growth competence rather than actual ability 
to grow. 
a 
ap 0 2 6 20 48 h 
b 
3. Expression of c-fos in T and B Cells 
In contrast to the c-myc gene which was only 
expressed significantly in experimentally acti-
vated mouse lymphocytes, c-fos gene expres-
sion occurred without any manipulation short 
of the preparation of single cell suspensions 
from spleens. This was the case even in the ab-
sence of FCS or in the presence of mouse sera 
(Fig. 5). 
Depending on the time between preparation 
of single cell suspensions and RNA extraction 
and the temperature during isolation, demon-
strable levels of c-fos specific mRNA were de-
tectable at around 30 min of cell culture at 
37° C. RNA extracts obtained directly from 
mouse spleens did not give a c-fos specific sig-
nal in Northern blot analysis and SP6 mapping 
experiments. Thus the disruption of cell-cell 
contacts during preparation of spleen cell sus-
pensions may suffice to induce c-fos gene 
transcription in normal mouse lymphocytes 
c 
o 2 6 20 48 h a}J int 0 1.3 4 21 h 
myc. 
myc 
2.4 kb. myc. 
1.7 kb. 
H- 2 
Fig. 4: Cells were stimulated with a) anti ~ F(ab')2 at mitogenic concentrations (12,5 ~g/ml, resting B cells), b) LPS (10 
~g/ml, B cells) or c) intact rabbit anti ~ (resting lymphocytes). At the times indicated RNA was isolated, separated, blot-
ted and hybridized to a c-myc specific probe (b, c) and to a c-myc specific and an H-2 Cl I specific probe (a). 
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Fig. 5: Spleens were either directly dissociated in 
guanid inium/ isothiocyanate or processed for single cell 
suspensions. The latter were then cultured in RPM I con-
taining 5% mouse serum (MS), 5% fetal calf serum (FCS) 
or no serum. At the times indicated cells were harvested, 
RNA was isolated, separated, blotted and hybridized to a 
dos specific probe. 
even though the cells so manipulated do not 
acquire growth competence. This fact ham-
pers experiments which address the functional 
significance of antigen or mitogen induced c-
los gene expression in freshly isolated spleen 
cells. It may be worthwhile to consider this 
phenomenon also in context with other re-
ports on c-fos gene expression. 
Mechanisms Regulating Steady State Levels 
of c-myc and c-fos mRNA in Mouse Lym-
phocytes 
It is commonly observed that both the c-myc 
and c-fos genes are only transiently expressed 
in normal cells, the respective mRNA levels 
reaching a maximum (c-fos ca. 1 h, c-myc 
6-12 h post stimulation) and decreasing 
thereafte/,8 . This regulation of gene expres-
sion may occur at the transcriptional, the 
post-transcriptional level or by a combination 
of both control mechanisms. 
1. Transcriptional control mechanisms 
Nuclear run-on analyses showed that trans-
cription of the c-fos gene is already initiated in 
nuclei from lymphocytes isolated as described 
above. In contrast, complete c-myc gene 
transcription to a full1ength precursor mRNA 
depends on mitogenic activation and reaches a 
maximum rate 6 h post stimulation. Interest-
ingly, the first exon of c-myc is already trans-
cribed in nuclei from non-stimulated cells, but 
elongation stops at the exon lIintron 1 bound-
ary. Within this region the complementary 
strand is also transcribed in nuclei from un-
stimulated cells (Fig. 6). As a function of time 
post stimulation, the signal for this anti-sense 
RNA decreases while transcription of precur-
sor mRNA now proceeds to exons 2 and 3. 
The stop in elongation at the exonllintron 1 
boundary of the precursor mRNA and the 
concomitant anti-sense transcription in non-
activated cells may be mechanistically linked. 
Transcription from the anti-sense strand of 
myc have aJso been described for tumor 
cells 11 ,12. 
The nuclear run-on results also indicated that 
transcription at both the c-fos and c-myc gene 
loci, after having been induced, is sub-
sequently reduced. C-myc gene transcription 
continues at a low rate while that of the c-fos 
gene ceases entirely. However, the transcrip-
tional control alone cannot account for the 
kinetics of mRNA levels observed. Thus, ad-
ditional means of regulation must be opera-
tive. 
2. Post-transcriptional control mechanisms 
The mature mRNA of several genes including 
c-myc and c-fos have been found to be unusu-
ally unstable13, 14. This was borne out by deter-
mining their half-lives (t 1/2) (Fig. 7a and b). In 
doing so, it turned out that the decay rates of 
both c-myc and c-fos mRNAs change as a 
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Fig. 6: Transcription rates of c-myc and c-fos. 
a) The transcription or elongation rates of the c-myc, c-fos, H-2 and ribosomal genes in Iymphocytes were determined 
after various times by nuclear run-on analyses. Probes: 0,5 flg of single stranded M13 DNA were slot blotted on 
Hybond N filter; (-) indicates the probes detecting anti-sense RNA, (+) indicates the probes for positive sense 
RNA. . 
b) The upper part shows the location of probes a, b, c, d, e and f of the mouse c-myc gene, the lower part the location of 
probes a, b, c, d and e of the mouse c-fos gene. 
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Fig. 7: Determination of the half- lives of c-fos mRNA. 
a) Lymphocytes were cultured in RPMI 5% FCS with 2,5 f.lg/ml ConA. After 30 min (lanes 1- 5) 1 h (lanes 6- 15) and 
2 h (lanes 16-25) transcription was blocked by addition of 5 f.lg/ml Act D and cells were harvested 5,15,30,60 and 
120 min later. CHI (20 f.lg/m l) was added 30 min before add ition of Act D (lanes 11 - 15 and 21 - 25). The blot was 
hybridized with nick translated plasmid fos(M)780. The half-lives of c-fos mRNA were about 8 h for CHI treated 
lymphocytes, 70 min for 2 h ConA stimulated cells, about 25 min for 1 hand 14 min for 30 min stimulated lympho-
cytes. 
b) Lymphocytes were cultured in RPM I 5% FCS with 2,5 f.lg/ml ConA. After 2 h (lanes 1- 5) 6 h (lanes 6-15) and 48 h 
(lanes 16-25) transcription was blocked by addition of 5 f.lg/ml Act D and cells were harvested 5,15,30,60 and 120 
min later. CHI (20 f.lg/ml) was added 30 min before addition of Act D (lanes 11-15 and 21-25). The blot was hy-
bridized with nick-translated plasmid containing the 1.0 kb XbaI/Sstl fragment of the exon 2 of c-myc (mouse). The 
half-lives of c-myc mRNA were about 8 h for CHI treated lymphocytes, 50 min for 2 hand 6 h ConA stimulated cells, 
and 12 min for 48 h ConA stimulated lymphocytes. 
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function of time post stimulation. While the 
mRNA of c-fos displayed extreme instability 
at 30 min post stimulation (t 1/2 = 14 min), it 
became more stable later on (t 1/2 = 25 min at 
1 hand 70 min at 2 h). Conversely, the half-life 
of c-myc mRNA decreased from t 1/2 = 50 min 
at 2-6 h to t 1/2 = 12 min at 48 h post stimula-
tion. 
The lack of demonstrable c-fos mRNA before 
30 min in culture may be due to its initial insta-
bility. At a constant rate of transcription up to 
1 h post stimulation, steady state levels of c-
fos mRNA would then increase owing to in-
creasing mRNA stability. If, however, gene 
transcription is down-regulated at 2 hand 
later, the remaining mRNA would be lost 
rather rapidly due to its still relatively short 
half-life. On the other hand, the appearance of 
c-myc specific mature mRNA in activated T 
cells is exclusively accounted for by increasing 
rates of transcription now occurring over the 
entire gene. Steady state levels of c-myc 
mRNA are then reduced at constant rates of 
transcription by decreasing stability. Finally, 
while c-myc gene transcription persists at very 
reduced rates up to 48 h, the further increasing 
instability of the mature mRNA leads to its 
further gradual reduction. 
Summary and Conclusions 
In normal mouse splenic Band T cells at least 
two cellular proto-oncogenes are expressed, i. 
e. c-myc and c-fos. The expression of c-myc 
depends on the activation of the cells, but not 
on subsequent growth. C-fos gene expression 
appears to be induced by the manipulation in-
volved in preparation of single cell suspen-
sions from spleens. In that respect, c-fos gene 
expression does not qualify as being signific-
antly involved in transition from G 0 to S 
phase while expression of c-myc seems to be 
correlated with some early events of cell acti-
vation leading to growth competence. The 
kinetics and extent of c-myc gene expression 
vary with the mitogen used and the type of 
lymphocyte investigated as examplified by T 
cells and subpopulations thereof. The expres-
sion of both proto-oncogenes in normal 
mouse spleen cells is finely regulated by an in-
terplay of transcriptional and post-transcrip-
tional control mechanisms. These 
mechanisms operate differently for the two 
genes and independently from one another. 
They also change in predominance at various 
times, again independently from one another. 
While we have no evidence that c-fos has sig-
nificance for the activation of lymphocytes , c-
myc is a good candidate for being involved. 
Thus studies by Susan Corey and col-
laborators on transgenic mice which constitu-
tively express c-myc in cells of the lymphocyte 
lineage, indicate that this lineage is profoundly 
affected 15 . Among others, the effects concern 
the balance between proliferation and matura-
tion and a constitutive high level of la expres-
sion, normally only observed in activated 
cells. Constitutive high expression of c-myc in 
B cells of these transgenic mice also makes 
them prone to leukemia possibly due to a 
series of subsequent events. These last find-
ings also provide an explanation for the need 
for a very finely tuned regulation of c-myc 
gene expression as it is here described. 
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